Bloodstream Infections Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting bloodstream infections clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Albi, France, Angers, France, Basel, Canton of Basel-City, Switzerland. Updated daily from ClinicalTrials.gov.


Bloodstream Infections Trials at a Glance

7 actively recruiting trials for bloodstream infections are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Albi, Angers, and Basel. Lead sponsors running bloodstream infections studies include IRCCS San Raffaele, Istanbul Medipol University Hospital, and Boston Children's Hospital.

Browse bloodstream infections trials by phase

About Bloodstream Infections Clinical Trials

Looking for clinical trials for Bloodstream Infections? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bloodstream Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bloodstream Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland606 enrolled12 locationsNCT06958835
Recruiting

Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections

Laboratory-confirmed Bloodstream InfectionCentral Line-associated Bloodstream InfectionsMucosal Barrier Injury
Boston Children's Hospital60 enrolled1 locationNCT02271243
Recruiting
Not Applicable

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

Critical Care NursingIntensive Care (ICU)Central Venous Catheter Related Infections+2 more
University Hospital, Angers2,830 enrolled27 locationsNCT07183592
Recruiting
Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus Aureus BacteraemiaStaphylococcal Bacteraemia+1 more
Region Skane420 enrolled1 locationNCT06726395
Recruiting

INfectious DIsease REgistry BIObank

Bone and joint infectionsInfective EndocarditisCentral Nervous System Infections+4 more
IRCCS San Raffaele10,000 enrolled1 locationNCT06418048
Recruiting

Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections

Bloodstream InfectionsBacteremia and SepsisFungemia
Istanbul Medipol University Hospital300 enrolled1 locationNCT07408544
Recruiting

Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study

SepsisCritically Ill Intensive Care Unit PatientsBloodstream Infections
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT06791889